177 results
Page 3 of 9
8-K
EX-99.2
5em8eom x3fmlr6abuh
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
ow7u5j
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-1.1
w4derir677o
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
gz0m3re
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.1
sjlgiif5f202yb
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
x7b4b92m71l9 bzdy
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
h2g jg4wfo2
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
yro651g8i004uk
12 May 22
Departure of Directors or Certain Officers
4:10pm
8-K
EX-99.2
drze kdku9e97r
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
p6qplm
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
id46itqjekr
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
tf9jq5rb a1on3x
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
7gxm7cf
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
sm8g1bik504v sda9
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
q3nbey1n47k 0489bji3
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
vkwp3coehe4xyvc3vhx
14 Jun 21
Other Events
5:21pm